Bioengineered living cardiac and venous valve replacements: current status and future prospects

Abstract

Valvular heart disease remains to be a major cause of death worldwide with increasing prevalence, mortality, and morbidity. Current heart valve replacements are associated with several limitations due to their nonviable nature. In this regard, heart valve tissue engineering has shown to represent a promising concept in order to overcome these limitations and replace diseased cardiac valves with living, autologous constructs. These bioengineered valves hold potential for in situ remodeling, growth, and repair throughout the patient's lifetime without the risk of thromboembolic complications and adverse immune responses. For the fabrication of tissue-engineered heart valves, several concepts have been established, the "classical" in vitro tissue engineering approach, the in situ tissue engineering approach, and alternative approaches including three-dimensional printing and electrospinning. Besides first attempts have been conducted in order to produce a tissue-engineered venous valve for the treatment of deep venous valve insufficiency. Here we review basic principals and current scientific status of valvular tissue engineering, including a critical discussion and outlook for the future.

Uterine Tissue Engineering and the Future of Uterus Transplantation

“…The creation of bioengineered tissue parts is less complicated than the creation of complete organs and have in some areas successfully been clinically applied using biologically- or synthetically derived scaffolds; for example engineered skin-,4,69 bone-94 and heart valve grafts 50. Researchers have also clinically tested bioengineered constructs of “less complex” hollow structures such as urogenital tissues,3 blood vessels 57,71 and trachea 39,49,64.…”

Natural Scaffolds for Regenerative Medicine: Direct Determination of Detergents Entrapped in Decellularized Heart Valves

“…Overcoming the cytotoxicity of GFX tissues [6] would in turn open the way to possible repopulation by host cells, enabling xenogeneic viable substitutes to reshape and eventually grow with the host organism [7]. …”

Using a 3D printer in cardiac valve surgery: a systematic review

“…Surgical repair of valvular lesions, however, have limitations depending on the patient's conditions, congenital abnormalities, risk factors, comorbidities, and adverse immune responses. 3 In a systematic review, the authors mention different techniques used by 3D printers, among them is stereolithography, which fabricates a solid object from a photopolymer resin, and then laser light is then used to harden the surface layer of the polymer liquid. measurement of the cardiac system, resulting in longer-term benefits to the patient.…”